Literature DB >> 11786462

Screening for Down's syndrome. Antenatal screening has human costs.

Josephine Venn-Treloar.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11786462      PMCID： PMC1122000     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  Ultrasonographic femur-tibial length ratio: a marker of Down syndrome from the late second trimester.

Authors:  R Gupta; R D Thomas; V Sreenivas; S Walter; J M Puliyel
Journal:  Am J Perinatol       Date:  2001-06       Impact factor: 1.862

2.  Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies.

Authors:  R E Gilbert; C Augood; R Gupta; A E Ades; S Logan; M Sculpher; J H van Der Meulen
Journal:  BMJ       Date:  2001-08-25

3.  Antenatal screening for Down's syndrome.

Authors:  T M Reynolds
Journal:  Lancet       Date:  1998-10-03       Impact factor: 79.321

4.  Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study.

Authors:  J Hyett; M Perdu; G Sharland; R Snijders; K H Nicolaides
Journal:  BMJ       Date:  1999-01-09

5.  Nuchal translucency-screening without consent

Authors: 
Journal:  BMJ       Date:  1998-03-28

6.  Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses.

Authors:  G D Michailidis; D L Economides
Journal:  Ultrasound Obstet Gynecol       Date:  2001-02       Impact factor: 7.299

7.  Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects.

Authors:  E Mavrides; F Cobian-Sanchez; A Tekay; G Moscoso; S Campbell; B Thilaganathan; J S Carvalho
Journal:  Ultrasound Obstet Gynecol       Date:  2001-02       Impact factor: 7.299

Review 8.  Down's syndrome screening: a controversial test, with more controversy to come!

Authors:  T M Reynolds
Journal:  J Clin Pathol       Date:  2000-12       Impact factor: 3.411

9.  Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. British Paediatric Cardiac Association.

Authors:  C Bull
Journal:  Lancet       Date:  1999-10-09       Impact factor: 79.321

10.  Six year survey of screening for Down's syndrome by maternal age and mid-trimester ultrasound scans.

Authors:  D T Howe; R Gornall; D Wellesley; T Boyle; J Barber
Journal:  BMJ       Date:  2000-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.